CANF is seeking for partnerships (eg Company’s veterinary commercialization partner Vetbiolix) The sole reason for CANF to do the r/s is as another Bio company (MDWD) declared and done:
“We are effecting the reverse share split today as part of our strategic vision and long-term plan to increase shareholder value for MediWound. We believe a higher share price will help position MediWound more advantageously and attract new fundamental institutional investors, ahead of and post our numerous upcoming important milestones,” said Ofer Gonen, Chief Executive Officer of MediWound. “We have a promising future ahead of us, and this is just one of many steps we have taken to enhance shareholder value.”
Note: There is no connection between these 2 companies, besides the logic of the reverse split.